Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,500 shares at $79.08 ($579K) on 2013-09-16, disclosed to the SEC on 2013-09-17.
Scheduled sale ($579k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.40 | 3,085 | $236K | 40.7% |
| 2 | $77.44 | 2,895 | $224K | 38.7% |
| 3 | $78.38 | 1,320 | $103K | 17.9% |
| 4 | $79.08 | 200 | $16K | 2.7% |
| Total | $77.22 avg | 7,500 | $579K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |